Kiyoshi Hasegawa

3PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Aug 04, 2021
Clinical indicators useful in decision-making about palliative chemotherapy for end-of-life ovarian cancer patients.

Kaori Kiuchi, Kiyoshi Hasegawa, Mariko Watanabe

|Dec 03, 2019
Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms.

Wataru Yamagami, Mikio Mikami, Satoru Nagase

|Jul 24, 2019
Usefulness of imprint cytology of gonadoblastoma with dysgerminoma in a patient with Turner syndrome and a Y chromosome: A case report and literature review.

Tamiko Nagai, Kiyoshi Hasegawa, Emi Motegi

Pageof 1

Frequent Collaborators

1 joint publications

Wataru Yamagami

1 joint publications

Mikio Mikami

1 joint publications

Satoru Nagase

1 joint publications

Tsutomu Tabata

1 joint publications

Yoichi Kobayashi

1 joint publications

Masanori Kaneuchi

1 joint publications

Hiroaki Kobayashi

1 joint publications

Hidekazu Yamada

1 joint publications

Hiroyuki Fujiwara

1 joint publications

Hidetaka Katabuchi

Frequent Collaborators

1 joint publications

Wataru Yamagami

1 joint publications

Mikio Mikami

1 joint publications

Satoru Nagase

1 joint publications

Tsutomu Tabata

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on : Sep 15, 2023

1.7K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

Generation of Induced Pluripotent Stem Cells from Turner Syndrome (45XO) Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome (45XO) Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on : Dec 04, 2021

3.5K
See more related videos

Top Related Videos

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on : Sep 15, 2023

1.7K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on : Sep 12, 2019

Generation of Induced Pluripotent Stem Cells from Turner Syndrome (45XO) Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome (45XO) Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on : Dec 04, 2021

3.5K
See more related videos